TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment of Fibroblastic and Myofibroblastic Tumors
Source: Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 21, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Fibroblastic and myofibroblastic tumors have several subtypes, including the following:
Intermediate (locally aggressive).
Intermediate (locally aggressive).
Desmoid-type fibromatosis (previously called desmoid tumor or aggressive fibromatoses).
Source links and citations
Intermediate (rarely metastasizing).
Intermediate (rarely metastasizing).
Dermatofibrosarcoma protuberans not otherwise specified (NOS).
Source links and citations
Intermediate (rarely metastasizing).
Inflammatory myofibroblastic tumor.
Source links and citations
Intermediate (rarely metastasizing). › Inflammatory myofibroblastic tumor.
Epithelioid inflammatory myofibroblastic sarcoma.
Intermediate (rarely metastasizing).
Infantile fibrosarcoma.
Source links and citations
Malignant.
Malignant.
Sclerosing epithelioid fibrosarcoma.
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice